In Memoriam: David A. Flockhart, 1952-2015.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 89, doi. 10.1002/cpdd.258
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2016 AND VI 5 AND IP 2
Results: 9
1
2
Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 102, doi. 10.1002/cpdd.205
- By:
- Publication type:
- Article
3
Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed-dose combination compared with individual components: A phase 1, open-label, single-dose study.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 109, doi. 10.1002/cpdd.209
- By:
- Publication type:
- Article
4
Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 118, doi. 10.1002/cpdd.220
- By:
- Publication type:
- Article
5
Issue Information.
- Published in:
- 2016
- Publication type:
- Editorial
6
Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 91, doi. 10.1002/cpdd.193
- By:
- Publication type:
- Article
7
The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 131, doi. 10.1002/cpdd.214
- By:
- Publication type:
- Article
8
Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 150, doi. 10.1002/cpdd.213
- By:
- Publication type:
- Article
9
Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 141, doi. 10.1002/cpdd.238
- By:
- Publication type:
- Article